º»¹® ¹Ù·Î°¡±â

·Î±×ÀÎ ¹Ù·Î°¡±â


¹ÙÀÌ¿ÀŸÁöÄÚ¸®¾Æ(ÁÖ) ±â¾÷Á¤º¸

¹ÙÀÌ¿ÀŸÁöÄÚ¸®¾Æ(ÁÖ)

°ü½É±â¾÷ Ãß°¡Çϰí ä¿ë¼Ò½Ä ¹Þ±â

  • Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification.
  • ±â¾÷¸í¹ÙÀÌ¿ÀŸÁöÄÚ¸®¾Æ(ÁÖ)
  • ±â¾÷±Ô¸ðÁß¼Ò±â¾÷
  • ´ëÇ¥ÀÚ¼­Èñ¼±
  • ¼³¸³ÀÏ2016³â 6¿ù 29ÀÏ
  • ¸ÅÃâ¾× 59¾ï 5,512¸¸¿ø (2020)
  • »ç¿ø¼ö 12 ¸í ÀçÁ÷Áß
  • Æò±Õ¿¬ºÀ6,926¸¸¿ø
  • ÀÚº»±Ý 2¾ï 7,000¸¸¿ø

ȸ»ç¼Ò°³

ȸ»ç¼Ò°³

Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan and Korea.

The Biotage vision is to be the first choice for our employees, customers and shareholders by creating smart and efficient solutions in the fields of chemical synthesis and separations science.

Biotage is listed on the NASDAQ OMX Nordic Small Cap Stockholm. The stock exchange identity is BIOT.

À繫ÇöȲ

ÀÚº»ÃѰè¸ÅÃâ¾×¼øÀÌÀͰá»êÀÏ
6¾ï 4,391¸¸¿ø 59¾ï 5,512¸¸¿ø 1¾ï 5,553¸¸¿ø2020.12.31

´ÜÀ§: ¹é¸¸¿ø

°á»ê ³âµµÀÚº»ÃѰè¸ÅÃâ¾×¼øÀÌÀÍ
2020 6¾ï 4,391¸¸¿ø ¡è 59¾ï 5,512¸¸¿ø ¡è 1¾ï 5,553¸¸¿ø ¡è
2019 4¾ï 8,837¸¸¿ø ¡é 50¾ï 8,746¸¸¿ø ¡è- 1¾ï 3,878¸¸¿ø ¡é
2018 6¾ï 2,716¸¸¿ø 40¾ï 3,746¸¸¿ø 1¾ï 5,454¸¸¿ø

Á¤º¸Á¦°ø: ³ªÀ̽ºµð¿£ºñ

±â¾÷À§Ä¡

  • ÁÖ¼Ò : °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾çÇö·Î 322 803È£ (¾ßžµ¿,ÄÚ¸®¾ÆµðÀÚÀμ¾ÅÍ)
  • ȨÆäÀÌÁö : http://www.biotage.com

µ¿ÀÏ ±â¾÷ÀÌ¶óµµ Å¸Áö¿ª ä¿ëÀÇ °æ¿ì, ȸ»ç ÁÖ¼Ò¿Í Àα٠ÁöÇÏö Á¤º¸°¡ »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.